Teligent Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented) Pharmaceutical Investing
Intercept Pharmaceuticals Reports Full Year and Fourth Quarter 2017 Financial Results Pharmaceutical Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â